Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach

• Main Authors: Marco Mele (Author), Paola Imbrici (Author), Antonietta Mele (Author), Maria Vittoria Togo (Author), Giorgia Dinoi (Author), Michele Correale (Author), Natale Daniele Brunetti (Author), Orazio Nicolotti (Author), Annamaria De Luca (Author), Cosimo Damiano Altomare (Author), Antonella Liantonio (Author), Nicola Amoroso (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Sodium-glucose cotransporter type 2 inhibitors (SGLT2i), gliflozins, play an emerging role for the treatment of heart failure with reduced left ventricular ejection fraction (HFrEF). Nevertheless, the effects of SGLT2i on ventricular remodeling and function have not been completely und...